GovWire

Pharmacy2U / Lloyds Direct merger inquiry

Competition Markets Authority

January 23
11:00 2024

Statutory timetable

Date Action
19 March 2024 Deadline for phase 1 decision (*)
23 January 2024 Launch of merger inquiry
28 November 2023 Initial enforcement order

(*) This date is the current statutory deadline by when the decision will be announced. If any change occurs, the information is refreshed as soon as practicable. However, the CMA cannot guarantee that the decision will be announced on or before this current deadline, as the deadline of a given case may change during the merger assessment process due to different reasons.

Phase 1

Launch of merger inquiry

23 January 2024: The CMA announced the launch of its merger inquiry by notice to the parties.

Invitation to comment: closed on 6 February 2024

23 January 2024: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this merger has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

To assist it with this assessment, the CMA invites comments on the transaction from any interested party.

These comments should be provided by the deadline set out above.

Initial enforcement order

28 November 2023: The Competition and Markets Authority has served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on Pharmacy2U, P2U Holdings Limited, G Square Capital II L.P., G Square Healthcare Private Equity LLP and Lloyds Direct.

Amendments / consents granted

Contact

Please send written representations about any competition or public interest issues to:

Pharmacy2ULloydsdirect@cma.gov.uk

Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please see our Privacy Notice.

Published 30 November 2023
Last updated 23 January 2024 +show all updates
  1. Launch of merger investigation and commencement notice published.

  2. First published.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: